# SUGARFIT
[Home](/)
[How it Works](https://www.sugarfitglp.com/#why-glp)
[Why Sugarfit](https://www.sugarfitglp.com/#why-it-works)
[Success Stories](https://www.sugarfitglp.com/#success-stories)
[Our Team](https://www.sugarfitglp.com/#our-team)
[Plans](https://www.sugarfitglp.com/#plans)
[Blogs](https://www.sugarfitglp.com/#blogs)
[Book Free Consultation](https://www.sugarfitglp.com/)
# Sugarfit GLP-1 Glossary: Clear, India-Relevant Health Terms

This glossary explains important GLP-1, metabolic-health, nutrition, exercise and treatment-safety terms in plain language for readers in India. It is educational and does not replace an individual clinical assessment.

## Featured glossary guides

- [GLP-1](/what-is-glp-1-and-how-does-it-work)
- [Obesity management medication](/glossary/obesity-management-medication)
- [Obesity](/glossary/obesity)
- [Hypoglycaemia](/glossary/hypoglycaemia)
- [Ghrelin](/glossary/ghrelin)
- [Dehydration](/glossary/dehydration)
- [Acid reflux](/glossary/acid-reflux)
- [Lipid profile](/glossary/lipid-profile)

## GLP-1 and Medicine Terms

### GLP-1 receptor

The GLP-1 receptor is a protein on the surface of certain cells that receives the GLP-1 signal. Activation of this receptor can support glucose-dependent insulin release, reduce glucagon, slow digestion and influence appetite. Natural GLP-1 and GLP-1 receptor agonist medicines both use this pathway, but medicines are longer-acting and have product-specific effects and risks.

- **What this means in India:** The receptor explains how the pathway works, but each medicine can have different approved uses in India.
- **How this relates to GLP-1 care:** It is the main target of GLP-1 receptor agonist medicines.
- **Safety and when to seek help:** Medicine effects and warnings are product-specific. The receptor mechanism alone does not establish whether a medicine is suitable for someone.
- **Is the receptor itself a medicine?** No. It is a protein in the body; medicines activate it.

### Prescription medicine

A prescription medicine is a medicine that should be supplied and used under an authorised prescriber's direction. In India, Schedule H, H1 and X medicines carry specific prescription and dispensing controls. Prescription status signals the need for professional assessment and monitoring; it does not mean a medicine is suitable for every person with the relevant condition.

- **What this means in India:** Prescription status can differ between countries, so the current Indian label and Drugs Rules are the relevant references.
- **How this relates to GLP-1 care:** GLP-1 medicines used for diabetes or weight management require medical supervision and authorised supply.
- **Safety and when to seek help:** Do not share, resell, self-start or independently change prescription medicines.
- **Does a prescription make a medicine automatically safe?** No. It means a qualified prescriber must assess suitability and monitoring needs.

### Generic medicine

A generic medicine is generally intended to match an established reference medicine in active ingredient and relevant performance and quality requirements under the applicable regulator. A generic medicine is not the same thing as a generic name: the generic or nonproprietary name identifies the active substance, while an approved product may still be sold under a brand.

- **What this means in India:** In India, approval, manufacturer, strength, dosage form and authorised supply chain all matter; approval overseas does not establish approval in India.
- **How this relates to GLP-1 care:** Complex injectable or device-based products should not be assumed interchangeable solely because a molecule name matches.
- **Safety and when to seek help:** Do not substitute products or devices without the prescriber or pharmacist, especially for injectable medicines.
- **Is every product with the same molecule interchangeable?** No. Strength, formulation, device, indication and regulatory approval also matter.

### MEN2

MEN2 is an inherited syndrome, usually caused by a pathogenic RET gene variant, that greatly increases the risk of medullary thyroid carcinoma and can involve adrenal pheochromocytoma and parathyroid disease. It is not ordinary thyroid disease. Diagnosis and family screening require specialist genetic and endocrine care.

- **What this means in India:** Anyone with a personal or family history of MEN2 or medullary thyroid carcinoma should tell their clinician before medicine assessment. Product warnings should be checked against current Indian prescribing information.
- **How this relates to GLP-1 care:** Some GLP-1 medicine labels contain specific contraindications or warnings involving MEN2 or medullary thyroid carcinoma. Because these warnings differ by product, the current label for the specific medicine matters.
- **Safety and when to seek help:** People with suspected MEN2 or a relevant family history need specialist assessment; do not use an online glossary to decide medicine safety.
- **Is MEN2 the same as hypothyroidism?** No. MEN2 is an inherited tumour-predisposition syndrome involving endocrine glands.

### Non-response

Non-response means a treatment has not produced the agreed clinically meaningful benefit after an adequate, correctly used trial. The definition depends on the condition, medicine, dose stage, duration and outcomes being monitored. For obesity care, response includes more than one early weight reading and may include health, tolerability and adherence.

- **What this means in India:** Treatment response should be reviewed at the clinician-agreed point using the current Indian product label; overseas stopping rules do not automatically apply in India.
- **How this relates to GLP-1 care:** Before labelling GLP-1 treatment a non-response, clinicians may review dose progression, duration, adherence, injection technique, other medicines, nutrition, sleep, underlying conditions and whether goals were realistic.
- **Safety and when to seek help:** Do not increase dose, combine products or abruptly stop treatment in response to a plateau without the prescriber.
- **Is a short weight plateau non-response?** Not necessarily. Response must be judged over an adequate period using agreed outcomes and the correct treatment stage.

## Metabolic and Weight-Related Terms

### Class I obesity

Class I obesity is a BMI category, but its numerical range depends on the classification system. The global WHO adult system commonly uses 30.0-34.9 kg/m². Some Asian Indian clinical classifications use lower thresholds and may label 25.0-29.9 kg/m² as obesity grade or class I. Because classification systems differ, the stated BMI range should always identify which system it uses.

- **What this means in India:** Indian public-health screening commonly identifies obesity from BMI 25 kg/m², but the exact class labels can vary by guideline.
- **How this relates to GLP-1 care:** BMI category alone does not establish GLP-1 medicine eligibility; comorbidities, history and the Indian product label matter.
- **Safety and when to seek help:** BMI is a screening tool, not a complete diagnosis of individual health or body composition.
- **Why can two reports give different obesity classes?** They may be using global versus South Asian or Indian thresholds.

### Adipocyte

An adipocyte is a specialised cell in adipose tissue that stores energy mainly as triglycerides. Adipocytes also release signalling molecules that help regulate appetite, insulin sensitivity, inflammation and energy balance. They are active metabolic cells, not inert storage bags, and different adipose depots can have different health effects.

- **What this means in India:** There is no separate India-specific threshold for adipocytes, and they cannot be counted or felt directly in routine care.
- **How this relates to GLP-1 care:** Weight-management treatment can change adipose-tissue mass and metabolic signals, but routine GLP-1 care does not measure individual adipocytes.
- **Safety and when to seek help:** Do not use the term to diagnose metabolic disease without clinical measurements.
- **Is an adipocyte the same as body fat?** It is one cell type within adipose tissue; body fat includes many cells and structures.

### Diabetic ketoacidosis

Diabetic ketoacidosis is a life-threatening emergency caused by severe insulin deficiency, leading to high ketones and dangerous blood acidity. Symptoms may include extreme tiredness, nausea, vomiting, abdominal pain, dehydration, deep or difficult breathing, fruity-smelling breath and fainting. It most often affects type 1 diabetes but can occur in type 2 diabetes.

- **What this means in India:** Suspected DKA needs emergency evaluation and should not be managed through online advice.
- **How this relates to GLP-1 care:** DKA is not the same as nutritional ketosis. People with diabetes who are unwell need their clinician's sick-day and ketone-testing plan, regardless of GLP-1 use.
- **Safety and when to seek help:** Suspected DKA requires immediate emergency medical care.
- **Is DKA just very high blood sugar?** No. It involves ketone accumulation and acidosis and can be life-threatening.

### Obstructive sleep apnoea

Obstructive sleep apnoea is a sleep disorder in which the upper airway repeatedly narrows or closes during sleep, interrupting breathing. Loud snoring, gasping, witnessed pauses, morning headache and daytime sleepiness are common clues. Diagnosis generally requires clinical assessment and a sleep study; snoring alone does not confirm the condition.

- **What this means in India:** Severe daytime sleepiness can make driving or work unsafe and warrants an appropriate sleep evaluation.
- **How this relates to GLP-1 care:** OSA is associated with obesity and cardiometabolic risk. Weight management may help some people, but it does not replace prescribed airway treatment or follow-up.
- **Safety and when to seek help:** Breathing pauses and severe daytime sleepiness warrant prompt assessment; avoid driving if sleepiness makes it unsafe.
- **Does everyone who snores have OSA?** No. A clinical assessment and usually a sleep study are needed.

### Perimenopause weight gain

Perimenopause is the transition leading up to menopause, when hormone levels and menstrual patterns change. Some women notice weight gain or a shift toward more abdominal fat during this life stage, but ageing, reduced muscle mass, sleep disruption, activity, medicines and other health conditions can also contribute.

- **What this means in India:** Assessment may include menstrual history, symptoms, medicines, thyroid or metabolic concerns and reproductive potential, because weight change should not automatically be attributed to hormones.
- **How this relates to GLP-1 care:** A GLP-1 medicine is not a treatment for perimenopause itself. Weight-management eligibility and safety require separate assessment, including pregnancy possibility and the product-specific label.
- **Safety and when to seek help:** Seek assessment for very heavy or unexpected bleeding, rapid unexplained weight change, severe pelvic symptoms, pregnancy possibility or significant mood symptoms.
- **Does perimenopause always cause weight gain?** No. Experiences vary, and several age-related, behavioural and medical factors may contribute.

## Nutrition Terms

### Binge eating

Binge eating describes episodes of eating an unusually large amount of food with a sense of loss of control. Binge-eating disorder involves recurrent episodes and significant distress and requires assessment by a qualified health or mental-health professional. It is not simply overeating occasionally, and it should not be treated with shame or restrictive punishment.

- **What this means in India:** Support should use non-stigmatising language and, where needed, culturally appropriate mental-health or eating-disorder care.
- **How this relates to GLP-1 care:** Appetite change during weight treatment does not by itself treat the emotional, behavioural and mental-health dimensions of binge-eating disorder.
- **Safety and when to seek help:** Seek professional help for recurrent loss-of-control eating, purging, severe restriction, depression or self-harm thoughts.
- **Is every large meal a binge?** No. Loss of control, recurrence and distress are important distinctions.

### Legumes

Legumes are plants in the pea and bean family. Their edible seeds include lentils, chickpeas, beans and peas; dried edible seeds are often called pulses. They can provide plant protein, carbohydrate, fibre and micronutrients. In Indian meals, dal, rajma, chana and many regional pulses are familiar examples.

- **What this means in India:** Portion size, preparation, oil and accompaniments change the nutritional profile of a meal, so dal is not automatically low-calorie.
- **How this relates to GLP-1 care:** Fibre- and protein-containing foods may support meal quality and fullness during GLP-1 care, but individual tolerance and nutrition needs vary.
- **Safety and when to seek help:** People with digestive symptoms, allergies or kidney-related dietary restrictions need individual advice.
- **Are pulses and legumes identical?** Pulses are the dried edible seeds of legume plants; legumes is the broader plant family.

### Refined carbohydrate

A refined carbohydrate usually refers to a grain or carbohydrate-rich food that has been processed to remove parts such as bran and germ, often reducing fibre and some micronutrients. Examples can include refined flour products and polished grains. The term is not identical to sugar, and processing level and the whole meal both matter.

- **What this means in India:** Maida is refined flour; rice varieties and preparation methods differ. Portion size and the overall meal matter more than labelling a food simply good or bad.
- **How this relates to GLP-1 care:** People experiencing early fullness on GLP-1 treatment may benefit from prioritising nutrient-dense foods, but rigid carbohydrate bans are not required for everyone.
- **Safety and when to seek help:** Diabetes meal planning and carbohydrate changes should account for glucose-lowering medicines and hypoglycaemia risk.
- **Are refined carbohydrates the same as added sugar?** No. Added sugar is one type of carbohydrate; refined grains may contain mostly starch.

## Exercise and Fitness Terms

### Aerobic exercise

Aerobic exercise is planned, repetitive activity that uses large muscle groups and raises breathing and heart rate for a sustained period. Brisk walking, cycling, swimming and dancing are common examples. WHO recommends regular aerobic activity alongside muscle-strengthening work, adjusted for age, ability, health and current fitness.

- **What this means in India:** Walking, cycling, swimming and dance can be adapted to climate, air quality, access and personal safety.
- **How this relates to GLP-1 care:** Aerobic activity supports cardiovascular fitness and metabolic health during weight-management care; it complements rather than replaces nutrition, strength work or prescribed treatment.
- **Safety and when to seek help:** People with concerning chest pain, fainting, severe breathlessness or unstable medical conditions need assessment before continuing exercise.
- **Is walking aerobic exercise?** Brisk walking can be aerobic when it raises breathing and heart rate to an appropriate intensity.

### VO₂ max

VO2 max is the highest rate at which the body can take in and use oxygen during intense exercise. It is a measure of cardiorespiratory fitness and may be measured in a laboratory or estimated by fitness tests and devices. Values depend on age, sex, body size, training, health and test method.

- **What this means in India:** Consumer wearables provide estimates, not diagnoses; compare trends only when device and test conditions are similar.
- **How this relates to GLP-1 care:** VO2 max can improve with training even when weight changes slowly. It is not a standard test of GLP-1 response.
- **Safety and when to seek help:** Maximal exercise testing should be supervised when medical history or symptoms raise concern.
- **Is a smartwatch VO2 max exact?** No. It is an estimate based on device algorithms and available sensor data.

## Clinical Assessment and Investigations

### DEXA scan

A DEXA or DXA scan uses low-dose X-rays to measure bone mineral density, usually at the hip and spine. Some scanners can also estimate body composition, but bone-density and body-composition reports answer different questions. A scan is ordered according to age, fracture risk, medical history and treatment monitoring needs.

- **What this means in India:** Before a scan, confirm whether it is for bone density or whole-body composition, because the reports answer different questions and require clinical interpretation.
- **How this relates to GLP-1 care:** DEXA is not routinely required solely because someone uses a GLP-1 medicine, but bone and lean-mass health may matter in broader weight-management assessment.
- **Safety and when to seek help:** Inform the imaging centre about pregnancy possibility and follow local preparation instructions.
- **Does DEXA directly measure every type of body fat?** No. It estimates tissue compartments and results depend on the scan protocol and machine.

### Clinical assessment

A clinical assessment is a structured evaluation that combines the person's concerns, medical and medicine history, symptoms, examination and relevant tests to guide diagnosis and care. In weight management it may include BMI and waist measures, blood pressure, glucose and lipids, sleep, eating patterns, mental health, reproductive plans and treatment preferences.

- **What this means in India:** India-relevant thresholds, current medicine indications, access and monitoring requirements should be considered during assessment.
- **How this relates to GLP-1 care:** A clinical assessment is required before deciding whether a GLP-1 medicine is suitable and while monitoring benefit, side effects and ongoing need.
- **Safety and when to seek help:** An online form or BMI calculator cannot replace examination and individual medical review when medicine is being considered.
- **Is a blood test alone a clinical assessment?** No. Tests are interpreted alongside history, symptoms, examination and goals.

---

*Educational information only. It does not diagnose a condition, establish treatment eligibility or replace advice from a qualified healthcare professional.*

## References

- [WHO: Obesity - GLP-1 therapies](https://www.who.int/news-room/questions-and-answers/item/obesity-glp-1-therapies)
- [WHO: Obesity and overweight](https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight)
- [Ministry of Health and Family Welfare: Prevention, screening and control of common NCDs](https://www.mohfw.gov.in/sites/default/files/Module%20for%20Multi-Purpose%20Workers%20-%20Prevention%2C%20Screening%20and%20Control%20of%20Common%20NCDS.pdf)
- [CDSCO: Drugs Rules](https://cdsco.gov.in/opencms/opencms/en/Acts-and-rules/Drugs-Rules/)
- [CDSCO: Bioavailability and bioequivalence](https://www.cdsco.gov.in/opencms/opencms/en/bioequi_bioavail/)
- [NIDDK: Low blood glucose (hypoglycemia)](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia)
- [NIDDK: Symptoms and causes of GER and GERD](https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/symptoms-causes)
- [NIDDK: Prescription medications to treat overweight and obesity](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity)
- [NHLBI: Sleep apnea](https://www.nhlbi.nih.gov/health/sleep-apnea)
- [NHLBI: Blood cholesterol diagnosis](https://www.nhlbi.nih.gov/health/blood-cholesterol/diagnosis)
- [NIMH: Eating disorders](https://www.nimh.nih.gov/health/publications/eating-disorders)
- [NCI: Multiple Endocrine Neoplasia Type 2](https://www.cancer.gov/publications/pdq/information-summaries/genetics/men2-hp-pdq)
- [MedlinePlus: Dehydration](https://medlineplus.gov/dehydration.html)
- [MedlinePlus: Bone density scan](https://medlineplus.gov/lab-tests/bone-density-scan/)
- [NIA: What is menopause?](https://www.nia.nih.gov/health/menopause/what-menopause)
- [WHO: Physical activity](https://www.who.int/initiatives/behealthy/physical-activity)
- [NCBI MeSH: Ghrelin](https://www.ncbi.nlm.nih.gov/mesh/?term=ghrelin)

## Navigation
- [Browse categories](https://blogs.sugarfitglp.com/topics)
- [Health glossary](https://blogs.sugarfitglp.com/topics/use_cases_workflows)

## Related AI KB pages

### GLP-1 for PCOS in India: Can Ozempic or Mounjaro Help with Irregular Periods and Weight?
Query: glp-1 for pcos in india can ozempic or mounjaro help with irregular periods and weight
If you have heard of Ozempic or Mounjaro for weight loss, you may be wondering whether these medications could also help with polycystic ovary syndrome (PCOS), one of the most c...
- [GLP-1 for PCOS in India: Can Ozempic or Mounjaro Help with Irregular Periods and Weight?](https://blogs.sugarfitglp.com/glp-1-for-pcos-in-india-can-ozempic-or-mounjaro-help-with-irregular-periods-and-weight)

### Lipid Profile: Tests, Units and Metabolic Health Meaning
Query: lipid profile meaning
A lipid profile is a blood test that commonly reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Some reports also include non-HDL cholesterol or cal...
- [Lipid Profile: Tests, Units and Metabolic Health Meaning](https://blogs.sugarfitglp.com/glossary/lipid-profile)

### Obesity: Meaning, Indian BMI Context and Health Relevance
Query: obesity meaning
Obesity is a chronic, relapsing disease involving excess or abnormal body-fat accumulation that can impair health. BMI is a practical screening measure, not a direct measure of...
- [Obesity: Meaning, Indian BMI Context and Health Relevance](https://blogs.sugarfitglp.com/glossary/obesity)

### GLP-1 and gut health
Query: GLP-1 and gut health
Most people think of GLP-1 medicines as appetite suppressants or weight-loss injections. But these medicines work primarily through the digestive system, where the natural GLP-1...
- [GLP-1 and gut health](https://blogs.sugarfitglp.com/glp-1-and-gut-health)

### Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained
Query: Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained
If you have heard about GLP-1 therapy for weight loss or blood sugar control and are wondering whether it applies to you, this guide explains the clinical criteria used in India...
- [Am I Eligible for GLP-1 in India? BMI, Conditions and Doctor Criteria Explained](https://blogs.sugarfitglp.com/am-i-eligible-for-glp-1-in-india-bmi-conditions-and-doctor-criteria-explained)

### BMI criteria for GLP-1 in India
Query: -BMI criteria for GLP-1 in India
GLP-1 therapy is not available to everyone, and the eligibility thresholds used in India differ from those applied in Western countries. Understanding the correct BMI cutoffs fo...
- [BMI criteria for GLP-1 in India](https://blogs.sugarfitglp.com/bmi-criteria-for-glp-1-in-india)